000525 Nanjing Red Sun
- 8.62
- -0.45-4.96%
Nanjing Red Sun News
Red Sun (000525) 2019 Interim Report Review: Weak Prices Are Dragging Down Performance and Optimistic About New Production Capacity Layout
Comments on the recent situation of Red Sun (000525)
Red Sun (000525) Quarterly report 2019 comments: short-term performance under pressure does not change long-term growth expectations
Red Sun (000525) 2018 Annual report comments: the decline in gross profit margin drags profits optimistic about long-term performance growth
Red Sun (000525) comments on major issues: the completion of the employee stock ownership plan to ensure the long-term development of the company
Comments on the major issues of Red Sun (000525): the new momentum of production growth of glyphosate project can be expected.
Red Sun (000525) Important Review: Proposed Acquisition of Chongqing's Zhongbang Industrial Chain to Collaborate to Promote Growth
Comments on Red Sun (000525) Quarterly report: steady revenue growth and environmental factors drag down earnings
Red Sun (000525) comments on major issues: employee stock ownership plan is optimistic about long-term performance growth
Red Sun (000525) report comments: capacity release and layout extension smoothly promote the company's performance growth prospects
红太阳(000525)年报点评：业绩增长符合预期 扩充产品线保障长期稳健增长
红太阳(000525)年报点评：一体化龙头份额加速提升 利润猛增符合预期
红太阳(000525)：业绩符合预期 吡啶碱一体化优势显著
红太阳(000525)点评：一季度业绩预告大幅增长 高于预期
红太阳(000525)：农药价格大涨业绩靓丽 产品扩张带来持续增长空间
红太阳(000525)一季度业绩预告点评：行业景气 战略明晰 公司一季度业绩喜人
红太阳(000525)点评：业绩增长超预期 新产能投放颠覆行业格局 产品梯队丰富助力公司腾飞
红太阳(000525)点评：公司业绩快报 17年归母净利润增长四倍之多
红太阳(000525)业绩预告点评：基本符合预期 长期看好吡啶碱龙头卡位优势
红太阳(000525)业绩快报点评：业绩如期靓丽;海外加速拓展
No Data
